Iodine and the thyroid: too little, too much, and why both cause problems
Iodine is not the engine and not the oil. Iodine is the metal the part is made of. That is why there is no yes-or-no answer here, only a curve with two ends.
All articles from the thyroid cluster
There is hardly a topic argued about so firmly and documented so rarely. One side says iodine is poison in Hashimoto. The other swallows seaweed capsules in amounts nobody adds up. Both ends of the curve can do damage, and both can be described with numbers.
You are standing in front of the salt shelf. Two packets, almost identical. One says iodized salt, the other does not.
In the past you would simply have taken one. Since your diagnosis you read labels differently. In the forum it said that iodine is dangerous in Hashimoto. Your family doctor never mentioned it.
Many people with a thyroid condition know this moment. In my consultations I hear the question almost every week, mostly in the same form: do I have to throw out my iodized salt?
The honest answer needs a few paragraphs. Iodine is not a nutrient you can discuss with a yes or a no. It is the building material the hormone is made of. With that, the question is never whether, but how much and into which gland.
What awaits you here
- Why no thyroid hormone is made without iodine, not little, but none
- The deficiency side: goiter, brain development and a public health success
- Where Germany stands today, with the numbers from DEGS, KiGGS and DONALD
- Pregnancy and breastfeeding: the highest requirement in a whole lifetime
- Wolff-Chaikoff and the escape phenomenon: the built-in emergency brake
- The U-curve towards autoimmunity, including the German counter-evidence
- The Hashimoto question: high doses and why strict avoidance does not fit either
- Invisible iodine sources: kelp, contrast media, amiodarone, disinfection
- Why a single urinary iodine value says little about you
Iodine is not one nutrient among others. It is the raw material itself
Think of magnesium for a moment, or of vitamin C. Both are helpers. They stand beside things and make reactions possible.
Iodine does something else. Iodine does not sit next to the hormone, it sits inside the hormone.
The thyroid hormone T4 has the full name tetraiodothyronine. Four iodine atoms. T3 is called triiodothyronine, three iodine atoms. Roughly two thirds of the molecular weight of T4 is simply iodine. Without iodine, little hormone is not produced. None is.
The gland handles this raw material accordingly. It does not wait for iodine to come by. It actively pumps it out of the blood, against a concentration gradient.
A working group around Nancy Carrasco, who described the transporter at the molecular level in 1996, summarised the state of knowledge on the sodium-iodide symporter in 2017, NIS for short. NIS brings iodide actively into the cell, also works in salivary glands, stomach and the lactating breast, and is adjustable, meaning it can be turned up and down.
For you that means: the gland is not at the mercy of the iodine supply. It can throttle uptake. This regulation is the thread running through this article.
Ravera S, Reyna-Neyra A, Ferrandino G et al. Annu Rev Physiol. 2017;79:261-289. PMID: 28192058 · DOI: 10.1146/annurev-physiol-022516-034125 [Mechanism Review]After that, an enzyme called thyroid peroxidase, TPO for short, attaches the iodide to a large protein called thyroglobulin. This step is called organification. Remember it, it comes up again later.
The iodinated thyroglobulin is then stored in the follicle. In generous amounts. The thyroid keeps a reserve of its own raw material, depending on the starting situation for weeks to months.
Exactly this reserve is the reason why iodine deficiency stays silent for a long time. Not because it would be harmless, but because a full warehouse hides an empty supply chain. What you notice first is therefore the reaction of the gland, not the deficiency.
The same molecule governs basal metabolic rate, heat production and the maturation of the nervous system. Seen through the KPNI lens, the thyroid sits at a crossroads of metabolism, hormonal system and nervous system. A building material for three systems is not negotiable.
And now you know why the iodine question has a different quality from the question about any given food supplement.
The deficiency side: goiter, brain development and the greatest success of this field
Look at old photographs from the Alps, from the Valais or from Tyrol. In many pictures you see thick necks.
That was no coincidence. Those were iodine deficiency areas, far from the sea, with iodine-poor soils. And what you see is the visible part of a long chain.
The chain goes like this. If too little iodine arrives, the pituitary sends more TSH. TSH is not only a production order, it is also a growth stimulus. First the gland grows evenly larger, which is called diffuse goiter. Over years nodules develop, and in some of them cells keep working without TSH. That is functional autonomy.
If you want to know how nodules and goiter are assessed today, that is covered in detail in Assessing nodules and goiter. Here I stay with iodine.
A Canadian working group around Karim Bougma evaluated 23 studies on iodine and mental development in children up to five years, separated by four study designs. The mean effect sizes were 0.68 in the randomised studies and between 0.46 and 0.54 in the observational studies, which converts to 6.9 to 10.2 IQ points.
For you that means: the authors name the weaknesses themselves, small sample sizes and unaccounted confounders. This is not a precision landing, but it is an order of magnitude.
Bougma K, Aboud FE, Harding KB, Marquis GS. Nutrients. 2013;5(4):1384-1416. PMID: 23609774 · DOI: 10.3390/nu5041384 [Meta-analysis, k=23]Sarah Bath and Margaret Rayman measured iodine in stored urine samples from 1,040 British pregnant women of the ALSPAC cohort, collected in the first trimester. Children of women with an iodine to creatinine ratio below 150 micrograms per gram landed more often in the lowest quarter of verbal IQ at age eight, with an odds ratio of 1.58.
For you that means: this is not about severe deficiency with a visible goiter, but about mild and inconspicuous, in a country that was not considered a deficiency country.
Bath SC, Steer CD, Golding J et al. Lancet. 2013;382(9889):331-337. PMID: 23706508 · DOI: 10.1016/S0140-6736(13)60436-5 [Cohort, n=1,040]This is why iodine deficiency is still regarded as the most common preventable cause worldwide of goiter and of impairments in mental development. Michael Zimmermann puts the weighting like this in his standard review: the comparatively small risks of iodine excess are far outweighed by the substantial risks of iodine deficiency.
When you read in a moment about the shadow side of too much iodine, keep this weighting in mind. The deficiency side is the bigger construction site. It is only quieter.
Anyone who thinks about iodine only from the excess side inverts the order of magnitude. Anyone who thinks about it only from the deficiency side overlooks the people for whom too much can be a problem. This article tries to take both equally seriously.
And now you know why a blanket recommendation to avoid iodized salt would not be a harmless one.
Where Germany stands today, and why supply is falling again
You are probably thinking: iodine deficiency, that was back then. Old photographs, a solved problem.
I told it that way for a long time too. The numbers say something else. The most reliable German data come from two surveys by the Robert Koch Institute, evaluated on behalf of the responsible federal ministry: DEGS for adults and KiGGS for children and adolescents in two waves.
| Survey | Group | Median urinary iodine concentration | Classification |
|---|---|---|---|
| DEGS, 2008 to 2011 | Men | 69 µg/L | below the WHO corridor |
| DEGS, 2008 to 2011 | Women | 54 µg/L | clearly below the WHO corridor |
| KiGGS, 2003 to 2006 | Children and adolescents | 118 µg/L | within the WHO corridor |
| KiGGS, 2014 to 2017 | Children and adolescents | 89 µg/L | fallen below the corridor |
| WHO reference | Population | 100 to 199 µg/L | target corridor for groups |
32 percent of adults in DEGS did not reach the estimated average iodine requirement, and among children and adolescents it was almost 44 percent. A second data series shows the trajectory even more sharply, because it works with genuine 24-hour urine collections.
Thomas Remer and colleagues evaluated 2,600 24-hour urine collections, gathered between 1985 and 2018 from 677 children of the Dortmund DONALD study. Median iodine excretion started at 40.1 micrograms per day, rose to a plateau of around 84.8 and fell to 58.9 by 2018. Sodium excretion had risen over the same period.
For you that means: people are not salting less, they are eating less iodized salt, presumably above all in industrial processing.
Remer T, Hua Y, Esche J, Thamm M. Eur J Nutr. 2022;61(4):2143-2151. PMID: 35043251 · DOI: 10.1007/s00394-022-02801-6 [Cohort, n=677, longitudinal]That has an uncomfortable consequence. By far the largest part of the salt you eat does not come from your shaker. It comes from bread, sausage, cheese, convenience products and eating out. If no iodized salt is used there, your shaker changes little about it.
The EUthyroid consortium around Till Ittermann and Henry Völzke had 40 studies from 23 European countries re-measured in a gold standard laboratory. Eleven laboratories had measured too high, ten too low, with deviations from minus 36.6 to plus 49.5 percent. After alignment, 7 of 13 studies in adults were below 100 micrograms per litre, and in pregnant women 7 of 11 were below 150.
For you that means two things. Iodine deficiency is not history in Europe, and the risk groups are adults and pregnant women. And iodine values vary considerably between laboratories, which matters for self-tests.
Ittermann T, Albrecht D, Arohonka P et al. Thyroid. 2020;30(9):1346-1354. PMID: 32460688 · DOI: 10.1089/thy.2019.0353 [Systematic Review, k=40]Now back to the question from the supermarket. Does one have to avoid iodized salt?
I deliberately give you no personal recommendation on this, in either direction. What I can give you are the reference values. The European Food Safety Authority derives 150 micrograms of iodine per day for adults and 200 for pregnant and breastfeeding women. As the tolerable upper intake level it names 600 micrograms, while for Germany the lower D-A-CH value of 500 applies.
The debate about iodized salt is conducted as if it were a decision at the kitchen table. According to the DONALD data it is above all a decision in the food industry.
And with a known thyroid condition, particularly with nodules showing autonomy, the iodine question is no longer a nutrition question anyway. It belongs in a medical conversation, with an eye on values and ultrasound.
And now you know why the statement "Germany is well supplied" and the statement "supply is falling" can both be true at the same time.
Pregnancy and breastfeeding: the highest requirement in a whole lifetime
There is one phase of life in which the iodine question is no longer a matter of taste.
The requirement rises for three reasons at once. The mother produces more hormone, the kidney excretes more iodine, and part of it goes to the child, the placenta and the amniotic fluid. In the first weeks the fetus produces no hormone of its own. Exactly during this time the first major maturation phase of the nervous system takes place.
This is why the reference values are higher. EFSA derives 200 micrograms per day for pregnant and breastfeeding women, and the American professional society ATA names 250 micrograms as total intake from diet and supplements. These are numbers from guidelines, not an instruction to you.
A group around Sueppong Gowachirapant and Michael Zimmermann randomised 832 pregnant women in Bangalore and Bangkok double-blind to 200 micrograms of iodine daily or placebo, on average from week 10.7. In the children at five to six years there was no difference in verbal IQ, performance IQ and executive function. The iodine status of the mothers was only mildly deficient.
For you that means: observation and intervention do not show the same thing here. The most plausible explanation is that week 10.7 is too late. Proven it is not.
Gowachirapant S, Jaiswal N, Melse-Boonstra A et al. Lancet Diabetes Endocrinol. 2017;5(11):853-863. PMID: 29030199 · DOI: 10.1016/S2213-8587(17)30332-7 [RCT, n=832]I deliberately let this contrast stand. Documented by large cohorts and a meta-analysis is the association between maternal iodine status and child development. Not documented is that a late supplement undoes it.
There is a counter-direction here as well. A position paper of the Teratology Society points out that the iodine content in combination supplements for pregnant women varies strongly, upwards as well as downwards. Why that matters you will see in the next section: the fetus defends itself against too much iodine less well than you do.
In pregnancy and while breastfeeding, different target values and a different framework of care apply. Iodine intake during this time belongs in medical hands, together with gynaecological support.
If you take thyroid medication, that applies doubly. Dose adjustments are frequent and sensible here, but they are made exclusively with medical supervision. Please do not change anything on your own. A neighbouring topic is iron balance, more on that in Iron deficiency in pregnancy.
The widespread idea is: in pregnancy you simply take more. The data rather say: what counts is getting neither clearly too little nor clearly too much. And the timing may matter more than the amount.
And now you know why in this section I explicitly ask you not to decide anything on your own.
Wolff-Chaikoff and the escape phenomenon: the built-in emergency brake
Imagine a small workshop. Every day it processes a manageable amount of material into a very potent product.
Now somebody dumps a thousand times that amount in front of the door. A well-organised workshop then shuts production down temporarily. Not because it is broken, but because otherwise a thousandfold excess of product would be made.
That is exactly what your thyroid does. The reflex has had a name since 1948. Jan Wolff and Israel Chaikoff described back then that high iodide concentrations inhibit hormone synthesis instead of driving it up. When you read somewhere that too much iodine damages the thyroid, that is the echo of this work, usually without the second part.
Wolff J, Chaikoff IL. J Biol Chem. 1948;174(2):555-564. PMID: 18865621 (no DOI assigned) [Foundational study, historical]
Four steps from the iodine flood back to normal operation
- The flood. A very high amount of iodine reaches the gland, for example from a supplement, a contrast medium or a drug.
- The emergency brake. Iodine-containing protein fragments called iodopeptides presumably form. They temporarily inhibit the production of thyroid peroxidase.
- The escape. After a few days the cell as a rule throttles the sodium-iodide symporter. Less iodide comes in, the concentration in the tissue falls, and the enzyme system can take up its work again.
- Normal operation. Production continues even though a lot of iodine is present on the outside. For the vast majority the story ends here.
The escape is the normal case, not the exception. That is why most people notice nothing of a one-off iodine flood. After Markou 2001, mechanism review.
Kostas Markou and colleagues from Patras summarised in 2001 what was known about iodine-induced hypothyroidism 52 years after Wolff and Chaikoff, and list the groups in whom the escape can fail to occur. The hypothyroidism is then mostly temporary, and a proportion later develop a permanent one.
For you that means: this review explains both ends of the topic. It is also the reason why caution towards high-dose iodine in autoimmune thyroiditis is physiology and not ideology.
Markou K, Georgopoulos N, Kyriazopoulou V, Vagenakis AG. Thyroid. 2001;11(5):501-510. PMID: 11396709 · DOI: 10.1089/105072501300176462 [Mechanism Review]Who escapes the Wolff-Chaikoff effect less reliably
- Fetuses and newborns. The maturation of this control loop is not yet complete.
- People with autoimmune thyroiditis, even with currently normal values.
- People after radioiodine therapy, thyroid surgery or on antithyroid drugs.
- People after postpartum thyroiditis or subacute thyroiditis.
- People on interferon alpha and a proportion of people with chronic systemic illnesses.
- A proportion of apparently healthy people, who cannot be identified reliably in advance.
A Brazilian group around Juliana Calil-Silveira examined the consequences of iodide excess in the rat thyroid cell line PCCl3. After 24 hours there was more of the transport protein pendrin, more of it sat in the cell membrane, and iodide efflux was increased.
For you that means: there is a second protective route besides throttling uptake. The caveat: these are cells in a culture dish, not people.
Calil-Silveira J, Serrano-Nascimento C, Kopp PA, Nunes MT. Am J Physiol Cell Physiol. 2016;310(7):C576-C582. PMID: 26791486 · DOI: 10.1152/ajpcell.00210.2015 [In vitro]A team around Michelle Hardley described fetal hypothyroidism with goiter after unintentional maternal iodine overdosing from over-the-counter fertility supplements. In the womb the fetus could not escape the Wolff-Chaikoff effect. Serial blood samples showed the escape only in the middle of the third trimester.
For you that means: the iodine source was not a drug, it was a food supplement. A single case documents no frequency, but it documents that it is possible.
Hardley MT, Chon AH, Mestman J et al. Horm Res Paediatr. 2018;90(6):419-423. PMID: 29791909 · DOI: 10.1159/000488776 [Case Report, n=1]So much for the direction in which too much iodine makes too little hormone. There is a second one, and it is the more dangerous.
Do you remember functional autonomy? Autonomous areas do not listen to TSH. They lack the regulator that brakes when supply is high, and they simply process whatever arrives. Out of this comes iodine-induced hyperthyroidism, often called Jod-Basedow. The German Federal Institute for Risk Assessment names this risk explicitly: a potentially life-threatening derailment, even after a single serving of very iodine-rich seaweed in someone with unrecognised autonomy.
If one of these signs appears after contrast media, a new supplement or an iodine-containing drug, it belongs in medical hands promptly. In the direction of hyperthyroidism:
- a racing heart at rest or an irregular pulse, especially newly occurring atrial fibrillation
- unintended weight loss despite normal or increased appetite
- inner restlessness, trembling hands, sleeplessness, feeling hot, heavy sweating
- muscle weakness, especially in the thighs
The most severe form is thyroid storm with high fever, racing heart, vomiting and impaired consciousness. It is an emergency and belongs in the emergency department immediately.
It can also tip in the other direction, namely when the escape fails to occur and production stays braked. These signs belong in medical hands just as much:
- increasing fatigue, cold sensitivity and slowing over weeks
- weight gain without a change in diet, constipation, dry skin
- a newly growing or pressing goiter, hoarseness, difficulty swallowing
- in newborns poor feeding, striking sleepiness and a prolonged newborn jaundice
The most severe form of this direction is myxedema coma with marked slowing, hypothermia and clouded consciousness. That too is an emergency. Both extremes are rare. Both are the reason why new complaints after an iodine load are assessed medically and not tackled on your own.
Seen through the lens of toxicology this is familiar. It is not the substance that decides, but the dose, the time course and the susceptibility of the person receiving it.
The common narrative goes: too much iodine damages the thyroid. More precise would be: the thyroid has an emergency brake against too much iodine, and in most people it works.
The problem is not the brake. It arises where the brake jams, or where a piece of tissue is no longer connected to it at all.
And now you know why the same amount of iodine can have completely different consequences in two people.
Iodine and autoimmunity: a curve, not a direction
If you have read this far, you are waiting for an answer. Does a lot of iodine cause Hashimoto or not?
The data do not give a direction. They give a shape. And this shape is a U.
Risk rises at both ends
Schematic, after the dose-response meta-analysis by Wang and colleagues across 22 studies with 69,987 participants. The odds ratios come from the accompanying cross-sectional study, each against the group with more than adequate supply. The curve illustrates the shape, it is not an exact risk function.
A Chinese group around Bingxuan Wang examined 2,808 adults and additionally calculated a dose-response meta-analysis across 22 studies with 69,987 participants. Compared with the group with more than adequate supply, the odds ratio for thyroid autoimmunity was 1.50 in iodine deficiency and 1.68 in iodine excess.
For you that means: the answer to good or bad is a curve. Its low point here was not at as little as possible, but at more than adequate.
Wang B, He W, Li Q et al. Eur J Endocrinol. 2019;181(3):255-266. PMID: 31252413 · DOI: 10.1530/EJE-19-0212 [Meta-analysis, k=22, n=69,987]The concern about the right end of the curve comes from several countries that raised their iodine supply and then looked closely.
Weiping Teng and colleagues followed 3,018 people in three Chinese regions over five years. The median urinary iodine concentration was 84, 243 and 651 micrograms per litre. The cumulative incidence of subclinical hypothyroidism was 0.2, 2.6 and 2.9 percent, and that of autoimmune thyroiditis 0.2, 1.0 and 1.3 percent.
For you that means: the relative difference is clear, the absolute one is small. Both readings belong together, otherwise statistics turn into alarm.
Teng W, Shan Z, Teng X et al. N Engl J Med. 2006;354(26):2783-2793. PMID: 16807415 · DOI: 10.1056/NEJMoa054022 [Cohort, n=3,018]The same group later compared two communities with 261 versus 145 micrograms per litre. TPO antibodies were positive in 10.64 versus 8.4 percent. Both supply situations would have been called good in Germany. From northwestern Greece comes a similar finding: among 302 schoolchildren in a former deficiency region, 9.6 percent had autoimmune thyroiditis, three times as often as seven years earlier. There, however, two cross-sections were compared, and antibody tests and ultrasound had improved in the meantime.
Inge Bülow Pedersen and Peter Laurberg registered every new case of overt hyperthyroidism in two Danish regions with 535,831 people, before and after salt iodization. Incidence rose from 102.8 to as much as 140.7 cases per 100,000 per year. The strongest relative rise, at 160 percent, was in the 20 to 39 year olds, where nodular goiters are rare.
For you that means: even a cautious iodization can raise the number of hyperthyroid cases, and it does not only affect old nodules.
Bülow Pedersen I, Laurberg P, Knudsen N et al. J Clin Endocrinol Metab. 2006;91(10):3830-3834. PMID: 16849408 · DOI: 10.1210/jc.2006-0652 [Cohort, n=535,831]The same working group broke down 1,682 new cases of hyperthyroidism across 2,027,208 person-years by cause. In the more iodine-poor Aalborg the incidence was 96.7 versus 60.0 per 100,000 in Copenhagen. The difference was almost entirely due to toxic nodular goiters and autonomous adenomas, while for Graves disease it was not significant. Iodine supply therefore mainly shifts which kind of hyperthyroidism arises.
And now comes the part I have not found in any German guide text on this topic.
In Western Pomerania what was feared did not happen
The Study of Health in Pomerania examined two population samples from northeastern Germany, 4,308 people around the year 2000 and 4,420 around 2010, each with ultrasound, TSH, TPO antibodies and urinary iodine.
Median iodine excretion fell from 123 to 112 micrograms per litre, and goiter prevalence from 35.1 to 29.4 percent. And TPO antibody positivity fell as well, from 3.9 to 2.9 percent. In this cohort, over ten years, exactly what the Chinese and Greek data give reason to fear did not happen. Anyone quoting only the alarming numbers tells half the story.
Khattak RM, Ittermann T, Nauck M, Below H, Völzke H. Popul Health Metr. 2016;14:39. PMID: 27833458 · DOI: 10.1186/s12963-016-0111-3 [Cohort, n=4,308 and n=4,420]How does that fit together? Honest answer: not completely. There is however a reading that explains a good deal.
Sandra McLachlan and Basil Rapoport evaluated the data on the loss of immune tolerance towards thyroid antigens. One of their core statements is that most environmental factors including an iodine excess unmask thyroid autoimmunity rather than create it.
For you that means: on this reading iodine is probably not the trigger, but it may co-determine the point in time at which an existing autoimmunity becomes visible. Why the immune system attacks the thyroid is covered in Hashimoto: causes in the immune system.
McLachlan SM, Rapoport B. Endocr Rev. 2013;35(1):59-105. PMID: 24091783 · DOI: 10.1210/er.2013-1055 [Mechanism Review]A second review arrives at the same point. Carlotta Teti and colleagues note that it remains unclear whether the immunological changes are a direct iodine effect or a secondary response to tissue damage. They remind us that antibodies and disease are not the same thing, more on that in Lowering Hashimoto antibodies.
In NOD.H-2h4 mice an autoimmune thyroiditis is induced by giving the animals 0.05 percent sodium iodide in their drinking water for eight weeks. Under this, thyroglobulin antibodies rise and the gland becomes infiltrated by lymphocytes. A methods paper notes that this strain develops the thyroiditis with or without iodine feeding, and that iodine merely intensifies it.
For you that means: no evidence for humans. It is a mouse strain bred specifically for this disease.
Liu X, Mao J, Han C et al. Mol Med Rep. 2016;13(4):3604-3612. PMID: 26935473 · DOI: 10.3892/mmr.2016.4965 [In vivo, mouse] · Qian Y, He L, Su A et al. J Vis Exp. 2023;(193). PMID: 37010279 · DOI: 10.3791/64609 [In vivo, mouse]That leaves the question of genes. A Chinese case-control study with 1,723 people found rising odds ratios up to 2.07 across the quartiles of iodine concentration, but no significant interaction with a genetic risk score. The association therefore does not appear to be limited to genetically burdened people. The relationship there was also nearly linear rather than U-shaped. This inconsistency belongs on the table.
A systematic review from 2025 across 31 studies after universal salt iodization sums up the practical consequence: what is decisive is not whether iodization happens, but whether monitoring detects oversupply.
The question "does iodine cause Hashimoto" carries an assumption that does not hold. It presumes a straight line with one direction.
What the data show is a corridor with two edges. And a factor that may make an existing predisposition visible is something other than a cause.
And now you know why honest answers to this question take longer than three sentences in a forum.
The Hashimoto question: high doses, strict avoidance, and why neither of them fits
Back to the salt shelf. You have Hashimoto and want to know what applies to you. I split this into two halves.
First half: why the caution is justified
People with autoimmune thyroiditis are on the list of those who escape the Wolff-Chaikoff effect less reliably, even when their values are currently unremarkable. That is the reason for the caution towards high-dose iodine in Hashimoto. Not a fashionable opinion, but regulatory physiology.
Farebrother and Zimmermann add: in a gland that is already damaged, an intake slightly above requirement can in some cases set off a functional disturbance. When a guideline advises against high iodine doses in autoimmune thyroiditis, it therefore has a physiological reason for it. That deserves respect, from a functional perspective too.
Second half: the study that is almost always quoted wrongly
Kanji Kasagi and colleagues from Kyoto asked 33 people with primary hypothyroidism to abstain from iodine-containing drugs and seaweed products for one to two months. Iodine intake in Japan ranges from 0.1 to 20 milligrams per day. Median TSH fell from 21.9 to 5.3 mU/L. The improvement, however, was not related to antibody titres, but to increased uptake on scintigraphy and increased levels of non-hormonal iodine.
For you that means: this is a study about iodine excess, not about Hashimoto. The authors state that the recovery was not statistically associated with Hashimoto. What can be transferred is: anyone carrying a considerable iodine overload may benefit from ending it. In the study protocol this abstention took place under medical supervision with laboratory follow-up, and that is exactly where it belongs outside a study too. Iodine-containing drugs are not dropped on your own.
Kasagi K, Iwata M, Misaki T, Konishi J. Thyroid. 2003;13(6):561-567. PMID: 12930600 · DOI: 10.1089/105072503322238827 [Intervention study, n=33]There is exactly one randomised trial on iodine restriction in an autoimmune thyroid disease. It concerns Graves disease, and its result points in a different direction than expected.
Hong Huang and colleagues randomised 459 people with newly diagnosed Graves disease over 24 months to adequate iodine intake or strict restriction. Urinary iodine concentration was 135 to 162 versus 30 to 58 micrograms per litre. The relapse rate after stopping antithyroid drugs was 35.5 versus 45.5 percent, and TRAb values were lower in the group with adequate supply.
For you that means: less iodine is not automatically the safe side in an autoimmune thyroid disease. The limitation: Graves is not Hashimoto, and the transfer remains an analogy.
Huang H, Shi Y, Liang B et al. Clin Endocrinol (Oxf). 2018;88(3):473-478. PMID: 29288501 · DOI: 10.1111/cen.13543 [RCT, n=459]With that the Hashimoto question can be summed up without me naming you an amount. In an autoimmune thyroid disease the target corridor is narrower than in other people. But it does not lie at zero.
From the lens of functional medicine a legitimate additional question arises here: not how much a population needs, but how high the individual total iodine load of a person currently is, with all supplements and drugs taken together. What this view cannot deliver at present is a validated marker for the individual case.
Hashimoto thyroiditis and Graves disease are chronic autoimmune conditions. No dietary measure and no food supplement replaces medical care.
Levothyroxine, antithyroid drugs and other long-term medications are never stopped, reduced or switched on your own. Every change is made exclusively with medical supervision. If you want to change something about your iodine intake after this article, the next step is a conversation and not an order.
Two topics I only touch on. What nutrition can achieve in Hashimoto is covered in Nutrition in Hashimoto, and the treatment of hyperthyroidism in Graves disease and hyperthyroidism. And selenium is closely involved in iodine metabolism, because the enzymes that release iodine from the hormone need selenium. Separate article: Selenium, zinc, iron and vitamin D.
Many people with Hashimoto are looking for a rule: iodine yes or iodine no. The data give no rule, they give a corridor. And the practically more important question is a different one anyway. Not: am I allowed iodized salt. But: where in my everyday life do large amounts of iodine come from unnoticed.
And now you know why on this matter I advise neither capsules nor strict avoidance.
The invisible iodine sources: seaweed, contrast media, amiodarone, disinfection
Now it gets practical. When somebody in Germany really does get too much iodine, it is almost never through iodized salt. Leung and Braverman put it like this: the source of the excess iodine is often not obvious.
Seaweed and kelp: practically the most important source
Inger Aakre and colleagues from the Norwegian marine research institute bought 96 macroalgae-containing products and determined the iodine content by mass spectrometry. Per portion the contents ranged from 128 to 62,400 micrograms, and in food supplements from 5 to 5,600 per daily dose. In 54 of the 96 products a single portion would have exceeded the upper intake level, and in several the labelling was wrong.
For you that means: a factor of about a thousand within the same product category is no longer scatter. The authors conclude that macroalgae-containing products are unreliable iodine sources.
Aakre I, Solli DD, Markhus MW et al. Food Nutr Res. 2021;65:7584. PMID: 33889064 · DOI: 10.29219/fnr.v65.7584 [Review, analytical and market study]Numbers from the BfR statement on dried seaweed
- 5 to 11,000 milligrams of iodine per kilogram dry weight is the documented range in dried seaweed and kelp products.
- 506 milligrams per kilogram was found in the product that was objected to. With a portion of 10 grams that is around 5,060 micrograms of iodine.
- Ten times the upper intake level of 500 micrograms per day applied for Germany, from a single portion.
- From 20 milligrams per kilogram upwards the BfR considers dried seaweed products unfit for sale, and between 10 and 20 it requires a warning notice.
- Named as risk groups: older people with functional autonomy, children with chronic excess, and people predisposed to an autoimmune thyroid disease.
The same document notes at the same time that in Germany on average about a third less iodine is taken in than recommended. Both sentences stand in the same regulatory assessment. That is the double nature of this topic.
A case report from Romania shows how that can feel: a 70 year old woman with no known thyroid condition developed hyperthyroidism with a racing heart, sleeplessness and six kilograms of weight loss three months after starting a kelp-containing slimming supplement. After stopping it and receiving antithyroid treatment, her values returned to the reference range.
Iodine-containing contrast media
Connie Rhee and colleagues from Boston compared 178 people with newly occurring hyperthyroidism and 213 with newly occurring hypothyroidism against 1,434 matched controls. Contrast media exposure was associated with an odds ratio of 1.98 for incident hyperthyroidism, and with 3.05 for overt hypothyroidism.
For you that means: the association is real, the absolute numbers are small. A well-founded CT scan is not cancelled because of this. The benefit lies in thinking of the thyroid when new symptoms appear after contrast media.
Rhee CM, Bhan I, Alexander EK, Brunelli SM. Arch Intern Med. 2012;172(2):153-159. PMID: 22271121 · DOI: 10.1001/archinternmed.2011.677 [Case-control study, n=1,825]A Taiwanese cohort of 98,210 people arrives at the same result, only with the weighting reversed: hazard ratio 1.46 overall, 1.22 for hyperthyroidism and 2.00 for hypothyroidism. That fits a rule from Laurberg: in iodine-replete regions hypothyroidism dominates after an iodine load, in iodine-poor regions hyperthyroidism does.
Amiodarone
Amiodarone is an antiarrhythmic drug, and every molecule carries two iodine atoms. Seo Young Sohn and colleagues evaluated the data of 27,023 people who received it for cardiac rhythm disturbances. 4.9 percent developed thyrotoxicosis and 11.5 percent hypothyroidism. The strongest independent risk factor in both directions was Hashimoto thyroiditis, with hazard ratios of 2.00 and 2.26.
For you that means: if you have Hashimoto and an antiarrhythmic drug is proposed to you, that is an argument for close monitoring. It is not an argument against the drug.
Sohn SY, Kim YJ, Cho S, Cho SW. Am J Cardiovasc Drugs. 2025;25(3):419-425. PMID: 39798058 · DOI: 10.1007/s40256-024-00717-6 [Cohort, n=27,023]The European guideline distinguishes two types of amiodarone-induced thyrotoxicosis. Type 1 is an iodine-induced hyperthyroidism in a nodular gland or in latent Graves disease and is treated with thionamides. Type 2 arises from a destructive inflammation in a previously normal gland and is treated with glucocorticoids.
In threatening cardiac rhythm disturbances amiodarone is often without an equivalent alternative. The European guideline therefore states that amiodarone-induced hypothyroidism is no reason to stop the drug. It is treated, and the drug continues. Whether amiodarone is continued is decided by cardiology and endocrinology together. This section is not an invitation to change anything.
Disinfection and radioiodine
Povidone iodine is an excellent antiseptic, and iodine is absorbed through the skin while it is used, especially with large-area application and in newborns. Conversely Zimmermann describes how the decline of such disinfection in hospitals has made iodine supply during parenteral nutrition a topic of its own. Here too, two ends.
Radioiodine therapy uses exactly the route from above: the sodium-iodide symporter preferentially brings radioactively labelled iodine into the overactive tissue. This is why a low-iodine preparation is required before radioiodine therapy, and this is why contrast media given shortly beforehand can postpone the therapy by weeks to months. This preparation is defined and supervised by the treating nuclear medicine department, it is not something you put together yourself. Everything further in Graves disease and hyperthyroidism.
In everyday life the iodine question is almost always negotiated at the salt shaker. There it is about micrograms. The amounts that can genuinely throw a thyroid off balance come from seaweed powder, kelp capsules, contrast media and drugs. There it is about milligrams.
And now you know why, with unclear thyroid values, my first question is not about salt but about the shelf with the food supplements and about the list of medications.
How you can assess your iodine status, and why one urine value is not enough
If you have read this far, you probably want to measure. And this is exactly where it gets uncomfortable.
Urinary iodine concentration is an excellent marker. For populations. For you as an individual person it says surprisingly little.
Franziska König and Michael Zimmermann collected 341 urine collections and 177 spot urines from 22 healthy women over 15 months. Variation within the same person was 32 to 38 percent. To determine individual iodine status with 20 percent precision, ten repeat measurements would have been needed.
For you that means: a single iodine value from a self-test gives a rough orientation, not a solid diagnosis. Together with laboratory deviations of up to 50 percent that gives a clear picture.
König F, Andersson M, Hotz K, Aeberli I, Zimmermann MB. J Nutr. 2011;141(11):2049-2054. PMID: 21918061 · DOI: 10.3945/jn.111.144071 [Cohort, prospective, n=22]That is no argument against measurement at population level, which works well. It is an argument against reading a single value as a personal diagnosis. Farebrother and colleagues discuss thyroglobulin as a supplementary marker, but for the individual case it is not established.
What carries more weight in practice is unspectacular: a thorough history of all iodine sources, meaning seaweed products, supplements, drugs and recent contrast media, plus thyroid values and ultrasound. How to read those values is covered in Thyroid blood values: which ones really count. Symptoms with unremarkable values are a topic of their own, see Normal values, symptoms anyway and Functional hypothyroidism.
The anthroposophic view of iodine
Anthroposophic medicine regards the thyroid as a place where substance and rhythm come together: an organ at the neck that co-determines the pace of metabolism. Iodine appears in this view as an element that comes from the sea and gives the organism a relation to the world that it cannot produce by itself.
I write this explicitly as a way of looking at things and as clinical tradition, not as a study finding. It stands beside physiology, not in its place. In more detail in The thyroid seen anthroposophically.
The question is rarely: how high is my iodine value. It is: how high is my total intake from all sources, and how sensitive is my gland right now. For the first there is currently no good single measurement. For the second there are history, values and ultrasound.
And now you know why I read a single self-test for iodine in urine only as a rough pointer.
With iodine there is no side you can safely take. There is only a corridor you should know.
Shukri JarmoukliFrequently asked questions about iodine and the thyroid
How much iodine does an adult need per day?
EFSA derives 150 micrograms per day for adults and 200 for pregnant and breastfeeding women, while the professional society ATA names 250 for that group. The tolerable upper intake level in Europe is 600 micrograms, for Germany 500. These are reference values for groups, not a personal prescription.
Is Germany still an iodine deficiency area?
Supply sits at the lower end. In DEGS the median urinary iodine concentration was 69 micrograms per litre in men and 54 in women, while the WHO corridor is 100 to 199. In children the value fell from 118 to 89. No longer a severe deficiency area, but declining again lately.
Should I use iodized salt or rather not?
This article neither advises you for it nor against it. Salt iodization counts as one of the most successful programmes in thyroid medicine, and the decline in Germany is mainly down to industrially processed foods. If you have a known thyroid condition, the question belongs in a conversation with your physician.
How would I notice an iodine deficiency?
For a long time you would not, because the thyroid holds a store that lasts weeks to months. If the deficiency persists, TSH rises, the tissue receives a growth stimulus, and a goiter can develop, over years also nodules and functional autonomy. Pressure in the neck or a lump sensation belongs in medical hands.
What is the Wolff-Chaikoff effect in simple words?
A built-in emergency brake. Wolff and Chaikoff described in 1948 that very high amounts of iodine temporarily inhibit the incorporation of iodine into the hormone. The gland protects itself from building very much hormone out of a sudden flood of material. It only becomes critical when the brake does not release again.
What does the escape phenomenon mean and why does it matter?
Escape is production starting up again after the emergency brake. After a few days the thyroid throttles its iodine pump, the concentration in the tissue falls, and production takes up its work again. Those who do not escape may develop iodine-induced hypothyroidism, for example fetuses, newborns and people with autoimmune thyroiditis.
May I take iodine if I have Hashimoto?
The guideline position is cautious towards high doses, not towards iodine as such. People with autoimmune thyroiditis escape the Wolff-Chaikoff effect less reliably, and that is the physiological reason. Basic requirement does not change because of Hashimoto. What fits belongs in a medical conversation, and existing medication is never changed on your own.
Should I avoid iodine completely if I have Hashimoto?
The data do not support that. The only randomised trial on iodine restriction in an autoimmune thyroid disease concerns Graves disease. There the relapse rate under strict restriction was 45.5 percent and under adequate intake 35.5 percent. Avoidance is therefore not automatically the safe side.
How much iodine is in kelp and seaweed supplements?
Very variable amounts. In a Norwegian market analysis of 96 products the iodine content per portion ranged from 128 to 62,400 micrograms. In 54 of the 96 products a single portion exceeded the upper intake level, and the labelling was wrong several times over. The BfR considers dried seaweed with 20 milligrams per kilogram or more unfit for sale.
Can a CT scan with contrast media harm my thyroid?
Contrast media bring a great deal of iodine into the body at once. In a case-control study exposure was associated with an odds ratio of 1.98 for newly occurring hyperthyroidism, and in a Taiwanese cohort the hazard ratio was 1.46. The absolute numbers are small, and a well-founded CT scan is not cancelled because of this.
What does amiodarone do to the thyroid?
Amiodarone contains a great deal of iodine. In a Korean cohort of 27,023 treated people, 4.9 percent developed thyrotoxicosis and 11.5 percent hypothyroidism. The strongest risk factor in both directions was Hashimoto thyroiditis. Whether amiodarone is continued is decided by cardiology and endocrinology together.
How can I have my iodine status measured?
Urinary iodine concentration is a good marker for populations and a weak one for individual people. In one study excretion varied within the same person by 32 to 38 percent, and about ten repeat measurements would be needed for 20 percent precision. History, thyroid values and ultrasound carry more meaning.
How much iodine do I need in pregnancy and while breastfeeding?
The requirement is highest during this time, because more hormone is produced, more is lost through the kidney and the fetus is supplied as well. EFSA derives 200 micrograms per day, the ATA names 250. This question belongs in medical hands and not in a forum.
What is iodine-induced hyperthyroidism and who is particularly at risk?
If parts of the thyroid work autonomously, meaning without control by TSH, they simply process the iodine that arrives. If a great deal suddenly arrives, hyperthyroidism can develop from it. Older people with nodules are particularly at risk. A racing heart, rhythm disturbances, tremor and weight loss belong in medical hands promptly.
Iodine, the thyroid and the rest of the body
The thyroid does not stand alone. It hangs on nutrients, on the gut barrier, on inflammation and on the burden coming from outside.
Cofactors of energy
Why nutrients only move something in interplay
Paleo, AIP and autoimmunity
What dietary approaches can achieve in autoimmune conditions
Gluten and the gut barrier
The neighbouring arena in Hashimoto, thought without coeliac disease
Iron and inflammation
How hepcidin blocks the iron route, a related pattern
Two neighbouring topics from the existing articles connect directly: Heavy metals and Hashimoto for the toxicological side and Iron deficiency, thyroid and sleep for energy and the night. How thyroid and cycle influence each other is covered in The thyroid and female hormones.
Scientific sources
- Ravera S, Reyna-Neyra A, Ferrandino G et al. The Sodium/Iodide Symporter (NIS). Annu Rev Physiol. 2017;79:261-289. PMID: 28192058 · DOI: 10.1146/annurev-physiol-022516-034125 [Mechanism Review]
- Portulano C, Paroder-Belenitsky M, Carrasco N. The Na+/I- symporter: mechanism and impact. Endocr Rev. 2013;35(1):106-149. PMID: 24311738 · DOI: 10.1210/er.2012-1036 [Mechanism Review]
- Wolff J, Chaikoff IL. Plasma inorganic iodide as homeostatic regulator. J Biol Chem. 1948;174(2):555-564. PMID: 18865621 (no DOI assigned) [Foundational study, historical]
- Markou K, Georgopoulos N, Kyriazopoulou V, Vagenakis AG. Iodine-induced hypothyroidism. Thyroid. 2001;11(5):501-510. PMID: 11396709 · DOI: 10.1089/105072501300176462 [Mechanism Review]
- Calil-Silveira J, Serrano-Nascimento C, Kopp PA, Nunes MT. Iodide excess regulates its own efflux. Am J Physiol Cell Physiol. 2016;310(7):C576-C582. PMID: 26791486 · DOI: 10.1152/ajpcell.00210.2015 [In vitro]
- Zimmermann MB. Iodine deficiency. Endocr Rev. 2009;30(4):376-408. PMID: 19460960 · DOI: 10.1210/er.2009-0011 [Systematic Review]
- Zimmermann MB, Boelaert K. Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol. 2015;3(4):286-295. PMID: 25591468 · DOI: 10.1016/S2213-8587(14)70225-6 [Review]
- Laurberg P, Cerqueira C, Ovesen L et al. Iodine intake as determinant of thyroid disorders. Best Pract Res Clin Endocrinol Metab. 2010;24(1):13-27. PMID: 20172467 · DOI: 10.1016/j.beem.2009.08.013 [Review]
- Bougma K, Aboud FE, Harding KB, Marquis GS. Iodine and mental development of children. Nutrients. 2013;5(4):1384-1416. PMID: 23609774 · DOI: 10.3390/nu5041384 [Meta-analysis, k=23]
- Bath SC, Steer CD, Golding J, Emmett P, Rayman MP. Inadequate iodine status in pregnancy and child cognition (ALSPAC). Lancet. 2013;382(9889):331-337. PMID: 23706508 · DOI: 10.1016/S0140-6736(13)60436-5 [Cohort, n=1,040]
- Gowachirapant S, Jaiswal N, Melse-Boonstra A et al. Iodine supplementation in pregnancy and child neurodevelopment. Lancet Diabetes Endocrinol. 2017;5(11):853-863. PMID: 29030199 · DOI: 10.1016/S2213-8587(17)30332-7 [RCT, n=832]
- Obican SG, Jahnke GD, Soldin OP, Scialli AR. Position paper: iodine deficiency in pregnancy. Birth Defects Res A. 2012;94(9):677-682. PMID: 22903940 · DOI: 10.1002/bdra.23051 [Review, position paper]
- Robert Koch-Institut und Bundesministerium für Landwirtschaft, Ernährung und Heimat. Jodversorgung in Deutschland, Jodmonitoring KiGGS und DEGS. Original document [Regulatory document]
- Remer T, Hua Y, Esche J, Thamm M. Iodine and salt intake in German children over 30 years. Eur J Nutr. 2022;61(4):2143-2151. PMID: 35043251 · DOI: 10.1007/s00394-022-02801-6 [Cohort, n=677]
- Ittermann T, Albrecht D, Arohonka P et al. Standardized Map of Iodine Status in Europe. Thyroid. 2020;30(9):1346-1354. PMID: 32460688 · DOI: 10.1089/thy.2019.0353 [Systematic Review, k=40]
- Khattak RM, Ittermann T, Nauck M, Below H, Völzke H. Thyroid disorders in Northeast Germany (SHIP). Popul Health Metr. 2016;14:39. PMID: 27833458 · DOI: 10.1186/s12963-016-0111-3 [Cohort, n=8,728]
- EFSA Panel on Dietetic Products, Nutrition and Allergies. Dietary Reference Values for iodine. EFSA Journal. 2014;12(5):3660. DOI: 10.2903/j.efsa.2014.3660 [Regulatory document]
- Leung AM, Braverman LE. Consequences of excess iodine. Nat Rev Endocrinol. 2014;10(3):136-142. PMID: 24342882 · DOI: 10.1038/nrendo.2013.251 [Review]
- Farebrother J, Zimmermann MB, Andersson M. Excess iodine intake: sources and effects. Ann N Y Acad Sci. 2019;1446(1):44-65. PMID: 30891786 · DOI: 10.1111/nyas.14041 [Review]
- Teng W, Shan Z, Teng X et al. Effect of iodine intake on thyroid diseases in China. N Engl J Med. 2006;354(26):2783-2793. PMID: 16807415 · DOI: 10.1056/NEJMoa054022 [Cohort, n=3,018]
- Teng X, Shan Z, Chen Y et al. More than adequate iodine intake and autoimmune thyroiditis. Eur J Endocrinol. 2011;164(6):943-950. PMID: 21444648 · DOI: 10.1530/EJE-10-1041 [Cohort, cross-sectional, n=3,813]
- Zois C, Stavrou I, Kalogera C et al. Autoimmune thyroiditis in schoolchildren after iodine repletion. Thyroid. 2003;13(5):485-489. PMID: 12855016 · DOI: 10.1089/105072503322021151 [Cohort, n=302]
- Bülow Pedersen I, Laurberg P, Knudsen N et al. Hyperthyroidism in young people after salt iodization, Denmark. J Clin Endocrinol Metab. 2006;91(10):3830-3834. PMID: 16849408 · DOI: 10.1210/jc.2006-0652 [Cohort, n=535,831]
- Carlé A, Pedersen IB, Knudsen N et al. Subtypes of hyperthyroidism in Denmark. Eur J Endocrinol. 2011;164(5):801-809. PMID: 21357288 · DOI: 10.1530/EJE-10-1155 [Cohort, 2,027,208 person-years]
- Wang B, He W, Li Q et al. U-shaped relationship between iodine status and thyroid autoimmunity. Eur J Endocrinol. 2019;181(3):255-266. PMID: 31252413 · DOI: 10.1530/EJE-19-0212 [Meta-analysis, k=22, n=69,987]
- Vargas-Uricoechea H, Castellanos-Pinedo A, Meza-Cabrera IA et al. Universal salt iodization and Hashimoto's thyroiditis. Diseases. 2025;13(6):166. PMID: 40558577 · DOI: 10.3390/diseases13060166 [Systematic Review, k=31]
- Teti C, Panciroli M, Nazzari E et al. Iodoprophylaxis and thyroid autoimmunity. Immunol Res. 2021;69(2):129-138. PMID: 33914231 · DOI: 10.1007/s12026-021-09192-6 [Review]
- McLachlan SM, Rapoport B. Breaking tolerance to thyroid antigens. Endocr Rev. 2013;35(1):59-105. PMID: 24091783 · DOI: 10.1210/er.2013-1055 [Mechanism Review]
- Li L, Ying YX, Liang J et al. Urinary iodine and genetic predisposition to Hashimoto's. Thyroid. 2020;30(12):1820-1830. PMID: 32746755 · DOI: 10.1089/thy.2020.0094 [Case-control study, n=1,723]
- Liu X, Mao J, Han C et al. Autoimmune thyroiditis in NOD.H-2h4 mice. Mol Med Rep. 2016;13(4):3604-3612. PMID: 26935473 · DOI: 10.3892/mmr.2016.4965 [In vivo, mouse]
- Qian Y, He L, Su A, Hu Y, Zhu J. Mouse model of spontaneous autoimmune thyroiditis. J Vis Exp. 2023;(193). PMID: 37010279 · DOI: 10.3791/64609 [In vivo, mouse]
- Kasagi K, Iwata M, Misaki T, Konishi J. Iodine restriction in primary hypothyroidism. Thyroid. 2003;13(6):561-567. PMID: 12930600 · DOI: 10.1089/105072503322238827 [Intervention study, n=33]
- Huang H, Shi Y, Liang B et al. Iodine supplementation versus restriction in Graves' disease. Clin Endocrinol (Oxf). 2018;88(3):473-478. PMID: 29288501 · DOI: 10.1111/cen.13543 [RCT, n=459]
- Aakre I, Solli DD, Markhus MW et al. Commercial kelp and seaweed products and iodine excess. Food Nutr Res. 2021;65:7584. PMID: 33889064 · DOI: 10.29219/fnr.v65.7584 [Review, market analysis n=96]
- Bundesinstitut für Risikobewertung. Gesundheitliche Risiken durch Jod in getrockneten Algen. Updated statement No. 026/2007 of 12 June 2007. Original document [Regulatory document]
- Gherbon A, Frandes M, Lungeanu D, Nicula M, Timar R. Transient hyperthyroidism after kelp-containing supplements. Medicine (Baltimore). 2019;98(37):e17058. PMID: 31517826 · DOI: 10.1097/MD.0000000000017058 [Case Report, n=1]
- Hardley MT, Chon AH, Mestman J et al. Iodine-induced fetal hypothyroidism. Horm Res Paediatr. 2018;90(6):419-423. PMID: 29791909 · DOI: 10.1159/000488776 [Case Report, n=1]
- Rhee CM, Bhan I, Alexander EK, Brunelli SM. Iodinated contrast media and incident thyroid dysfunction. Arch Intern Med. 2012;172(2):153-159. PMID: 22271121 · DOI: 10.1001/archinternmed.2011.677 [Case-control study, n=1,825]
- Kornelius E, Chiou JY, Yang YS et al. Iodinated contrast media and thyroid dysfunction, 6-year cohort. J Clin Endocrinol Metab. 2015;100(9):3372-3379. PMID: 26168278 · DOI: 10.1210/JC.2015-2329 [Cohort, n=98,210]
- Sohn SY, Kim YJ, Cho S, Cho SW. Amiodarone-induced thyroid dysfunction, nationwide cohort. Am J Cardiovasc Drugs. 2025;25(3):419-425. PMID: 39798058 · DOI: 10.1007/s40256-024-00717-6 [Cohort, n=27,023]
- König F, Andersson M, Hotz K, Aeberli I, Zimmermann MB. Ten repeat urine collections needed for individual iodine status. J Nutr. 2011;141(11):2049-2054. PMID: 21918061 · DOI: 10.3945/jn.111.144071 [Cohort, prospective, n=22]
- Alexander EK, Pearce EN, Brent GA et al. 2017 ATA Guidelines: Thyroid Disease During Pregnancy. Thyroid. 2017;27(3):315-389. PMID: 28056690 · DOI: 10.1089/thy.2016.0457 [Guideline]
- Bartalena L, Bogazzi F, Chiovato L et al. 2018 ETA Guidelines: Amiodarone-Associated Thyroid Dysfunction. Eur Thyroid J. 2018;7(2):55-66. PMID: 29594056 · DOI: 10.1159/000486957 [Guideline]
- Kahaly GJ, Bartalena L, Hegedüs L et al. 2018 ETA Guideline: Graves' Hyperthyroidism. Eur Thyroid J. 2018;7(4):167-186. PMID: 30283735 · DOI: 10.1159/000490384 [Guideline]